THE SIR GEOFFREY TODD TRUST

Registered charity 298597 · accounts filings on the Charity Commission register

Grants to individuals and organisations for medical and related purposes.

Causes: The Advancement Of Health Or Saving Of Lives · Get email alerts

Latest income
£35k
Latest spending
£58k
Registered
1988
Accounts read
FY2024

Financial health, per its FY2024 accounts

The accounts state that the Trust held unrestricted reserves of £340,453 at the year end, which is above its stated policy target of 18 months' expenditure. The Trust reports a net expenditure for the year, driven by a significant increase in charitable grants paid out, but maintains a strong financial position with adequate resources to continue in operational existence.

Automated summary of the FY2024 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Reserves policy: 18 months expenditure (held: £340k)
It is the policy of the Trust that unrestricted funds which have not been designated for a specific use should be maintained at a level equivalent to 18 months expenditure. — page 6
Per its FY2024 accounts as filed with the Charity Commission.

Accounts independently examined (not a full audit). Discloses 4 of 6 completeness components.

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Hampshire · Surrey · West Sussex

Income and spending

Financial year endIncomeSpending
31/12/2024£35k£58k
31/12/2023£35k£9k
31/12/2022£9k£53k
31/12/2021£10k£43k
31/12/2020£13k£21k

Common questions

Is THE SIR GEOFFREY TODD TRUST financially healthy?

Per its FY2024 accounts: The accounts state that the Trust held unrestricted reserves of £340,453 at the year end, which is above its stated policy target of 18 months' expenditure. The Trust reports a net expenditure for the year, driven by a significant increase in charitable grants paid out, but maintains a strong financial position with adequate resources to continue in operational existence. Its FY2024 accounts were independently examined.